Clone: | 8B5 |
|
Host: | Mouse |
|
Isotype: | IgG1 |
|
Immunogen: | Synthetic peptide corresponding to a portion of human c-Fos . |
|
UniProt ID: | P01100 |
|
Species reactivity: | Human, Mouse, Rat Dog
|
|
Applications: | ELISA, IHC, WB
|
|
Recommended Dilutions/Conditions: | ELISA (0.1µg/ml) Immunohistochemistry (1:50) Western Blot (0.5µg/ml, ECL) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
|
Application Notes: | Detects a band of ~50kDa by Western blot. |
|
Purity Detail: | Thiophilic adsorption and size exclusion chromatography purified. |
|
Formulation: | Lyophilized from 1ml of 2x PBS containing 0.09% sodium azide, PEG, and sucrose. |
|
Reconstitution: | Reconstitute with 1ml water (15 minutes at room temperature). |
|
Use/Stability: | Stable at -80°C up to 1 year, at 4°C up to 3 months. |
|
Shipping: | Blue Ice |
|
Long Term Storage: | -20°C |
|
Scientific Background: | The immediate early gene product c-Fos is expressed following mitogenic stimulation and functions as a sensor for MAPK signal duration. When MAPK activation is sustained, c-Fos is phosphorylated by MAPK at Ser374. Phosphorylation stabilizes the c-Fos protein and primes c-Fos for additional phosphorylation at Thr325. During transient MAPK activation, activity declines before accumulation of the c-Fos protein. |
|
Regulatory Status: | RUO - Research Use Only |
|
Immunohistochemistry analysis of human hepatoma tissue with c-Fos mAb (8B5).
Western blot analysis of serum -starved cancer cells A431 (1), A549 (2), SKOV3 (3), OVCAR5 (4), HaCaT (5), PC3 (6), HeLa (7) and HepG2 (8), probed with c-Fos mAb (8B5).